Provided research sources support that cranial electrotherapy stimulation / alternating current neurostimulation has been studied for mood and sleep-related outcomes, including depression and bipolar II depression, with several clinical trials cited by the company. The evidence shown here is suggestive but not definitive, and the available sources do not establish broad, high-certainty efficacy. Safety findings in the provided sources emphasize generally mild short-term side effects and important contraindications such as implanted electronic devices and pregnancy.

The Fisher Wallace Stimulator® is a device designed to treat the brain using electrical stimulation. It employs Transcranial Alternating Current Stimulation to modulate brain function and cognitive processes by influencing neural oscillations and promoting long-term synaptic plasticity. This technology can be used safely alongside medication or as a standalone therapy.

The device is convenient to use, requiring only 20 minutes of application after waking up and before going to bed. For those treating insomnia, a single session before bedtime is sufficient. The treatment is designed to fit easily into daily routines, allowing users to engage in activities like reading or watching TV during sessions.

Safety is a key feature of the Fisher Wallace Stimulator®, with over 100,000 users in the United States and no reports of long-term negative effects. While some users may experience mild, temporary side effects such as headaches or dizziness, these are rare. The device should not be used by individuals with certain medical conditions, such as those with implanted electronic devices or known heart disease, and it is not recommended for use during pregnancy.